Teladoc Inc (TDOC) Peer Comparison

$9.70

$0.81 (9.11%)

As on 04-Nov-2026 16:27EST

Market cap

$1,586 Mln

Revenue (TTM)

$2,468 Mln

P/E Ratio

--

P/B Ratio

1.2

Div. Yield

0 %

Edit

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Market cap ($ Mln)	1,586	13,359	10,590	6,930	2,371
Revenue ($ Mln)	2,468	6,338	5,674	2,661	1,959
Net Profit ($ Mln)	-154.82	644.40	399.12	282.40	150.09
Net Margin (%)	-6.27	10.17	7.03	10.61	7.66
RoE (%)	-11.77	18.46	16.19	33.04	17.37
Price to Earnings	--	21.74	27.01	25.61	15.95
Price-To-Book	1.23	4.82	4.25	8.04	2.67

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Operating Revenue	2,468.14	6,338.10	5,674.31	2,661.04	1,959.12
Cost of Revenue	661.96	3,896.00	4,838.38	1,818.79	1,453.07
Gross Profit	1,758.38	2,564.90	799.45	758.34	471.88
Operating Expenses	1,956.10	1,280.70	326.77	471.57	282.68
Operating Profit (EBIT)	-149.92	1,161.40	509.16	370.86	223.38
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-158.65	1,065.80	532.53	382.32	203.43
Provision for Tax	-3.83	218.80	133.02	99.92	53.34
Profit after Tax (Net Income)	-154.82	644.40	399.12	282.40	150.09
Minority Interest	0.00	-164.20	-0.39	0.00	0.00
Consolidated Profit	0.00	145.70	0.00	76.75	33.68

Liabilities ($ Mln)

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Shareholder's Funds	1,294.72	2,681.20	2,559.31	861.42	849.62
Minority Interest	0.00	-164.20	-0.39	0.00	0.00
Non-Current Liabilities	64.85	3,077.90	2,472.09	526.08	754.07
Current Liabilities	1,415.50	927.40	962.91	330.93	535.73
Total Liabilities	3,100.80	7,089.70	5,462.97	1,640.01	2,246.70

Assets ($ Mln)

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Non-Current Assets	1,549.07	6,553.50	4,843.51	1,352.71	1,455.34
Current Assets	1,226.01	1,013.00	1,154.88	365.73	684.08
Total Assets	3,100.80	7,089.70	5,462.97	1,640.01	2,246.70
Total Debt*	1,025.72	2,803.40	2,287.65	392.19	612.00
Net Current Assets	-189.49	0.00	191.97	0.00	148.35

Cashflow ($ Mln)

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Cash From Operating Activities	294.36	1,175.60	564.27	388.27	271.09
Cash Flow from Investing Activities	-266.00	-762.80	-513.18	-59.34	-18.30
Cash from Financing Activities	-551.65	-433.00	-11.81	-432.77	-107.49
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
ROCE (%)	-7.28	11.40	6.75	22.16	11.20
ROE (%)	-11.77	18.46	16.19	33.04	17.37
ROA (%)	-4.14	7.95	6.13	14.12	5.70
EBIT Margin (%)	-5.50	18.82	9.53	14.23	11.55
Net Margin (%)	-6.27	10.17	7.03	10.61	7.66
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Revenue Growth (%)	-2.38	9.36	17.49	5.15	1.91
EBIT Growth (%)	28.06	16.63	22.99	1.29	-3.82
Net Profit Growth (%)	30.76	19.11	21.61	1.29	-7.46
EPS Growth (%)	32.65	21.08	20.07	10.23	-2.78
Book Value Growth (%)	-10.17	15.90	20.05	-11.47	2.43

Valuation Ratios

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Price / Earnings	-6.16	19.12	30.03	22.57	10.92
Price / Book Value	0.89	4.44	4.63	6.11	2.09
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	10.13	9.54	24.49	14.37	7.17
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Debt to Equity	0.00	0.00	0.08	0.00	0.47
Short term debt to equity ratio	0.77	0.03	0.05	0.05	0.22
Current Ratio	0.87	1.09	1.20	1.11	1.28
Quick Ratio	0.84	1.09	1.20	1.08	1.28
Interest Coverage	-6.79	9.39	66.70	78.72	7.11

Operating Efficiency Ratios

	Teladoc Inc (TDOC)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Debtors to sales (%)	9.36	11.23	11.72	9.58	12.27
Asset Turnover	0.66	0.78	0.87	1.33	0.74
Receivable days	30.72	37.48	43.58	25.53	49.13
Inventory Days	18.07	--	--	1.62	--
Payable days	19.19	18.92	8.42	10.06	10.59
Cash Conversion Cycle	29.60	--	--	17.10	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly